Actemra/RoActemra® is the first FDA approved drug for treatment of serious or fatal cytokine release syndrome (CRS) caused by CAR-T therapy;
CAR-T cell therapy is an immunotherapy used t… Read More
Actemra – Risks & Side Effects
Those who suffer from rheumatoid arthritis rely on medications such as Actemra in order to enjoy a normal semblance of life. The problem is that this… Read More
Long-lasting treatments for invasive fungal disease are becoming ever more necessary but there are many challenges to overcome in drug development. Natalie Healey talks to Cidara Therapeutic… Read More
Roche (SIX: RO, ROG; OTCQX: RHHBY) is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaborati… Read More
Last updated: 14th April, 2020 Table of ContentsWhat is Actemra?Actemra compositionHistory behind the ActemraIndicationsHow does Actemra work? (Actemra Mechanism of
Action)How… Read More
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoAct… Read More
A new study has found that Actemra (tocilizumab) could have a favorable effect on critically ill COVID-19 patients, especially those who need mechanical ventilation. However, the drug has be… Read More
Clinical trials of the anti-inflammatory drug
tocilizumab (Actemra) for COVID-19 have begun in selected public and private
hospitals in Punjab.
Tocilizumab is immunosuppressive drug used… Read More
The global scleroderma therapeutics market size is expected to reach over USD 2.6 billion by 2026 registering a CAGR of 6.0%, according to a new study by Grand View Research, Inc. The market… Read More
The world’s top innovator bio-pharmaceutical businesses sense that while vaccines might ultimately bring an end to the coronavirus (Covid-19) pandemic, there… Read More
A recent study has revealed that an antibody-based blockade might effectively treat cytokine release syndrome (CRS) and alleviate severe cases of COVID-19.
The global race to develop a vacci… Read More
As one of only two treatments currently approved in the US for the treatment of COVID-19, Gilead’s remdesivir could soon be joined by Eli Lilly’s arthritis medication Olumiant (b… Read More
Roche says its Actemra drug reduces the severity of COVID-19 in hospitalised patients. The Swiss multinational healthcare company introduces a new COVID-19 test. Roche’s Tecentric-Avas… Read More
An Iranian version of Actemra, a medicine proved to help keep the coronavirus patients off ventilators, has been approved by the Iranian Food and Drug Administration and is now available at… Read More
SARS-CoV-2 Vaccines Inch Towards Regulatory Approval
Over the past month or so, investigators have been amassing data on SARS-CoV-2 candidate vaccines as quickly as possible and some of that… Read More
MRFR is the Leading Brand in The Research Company Who Recently Published Auto-Injectors Market Research Reports which includes Unique Research information, Market Dynamics, Drivers, and Tech… Read More
MRFR is the Leading Brand in The Research Company Who Recently Published Auto-Injectors Market Research Reports which includes Unique Research information, Market Dynamics, Drivers, and Tech… Read More
New Delhi: As COVID-19 cases across the country continue to rise at an alarming rate, West Bengal CM Mamata Banerjee on Sunday wrote a letter to Prime Minister Narendra Modi and requested th… Read More
MRFR is the Leading Brand in The Research Company Who Recently Published Auto-Injectors Market Research Reports which includes Unique Research information, Market Dynamics, Drivers, and Tech… Read More
A three-judge bench, headed by Chief Justice of Pakistan Gulzar Ahmed, heard the coronavirus suo motu case and expressed disappointment over a report submitted by the National Disaster Manag… Read More
The global interleukin inhibitors market size is expected to reach USD 74.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 17.4% over the forec… Read More
The global scleroderma therapeutics market size is expected to reach over USD 2.6 billion by 2026 registering a CAGR of 6.0%, according to a new study by Grand View Research, Inc. The market… Read More
Despite increasing vaccinations, the need for COVID-19 treatments has not gone away, particularly in light of vaccine shortages and rising case numbers in some countries around the world. Th… Read More
For Immediate Release: June 24, 2021 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospital… Read More
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (to… Read More
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two yea… Read More
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two yea… Read More
The World Health Organization (WHO) has backed the use of interleukin (IL)-6 receptor blockers as a COVID-19 treatment for severely or critically ill patients with the infection, alongside c… Read More
The World Health Organization (WHO) has backed the use of interleukin (IL)-6 receptor blockers as a COVID-19 treatment for severely or critically ill patients with the infection, alongside c… Read More
In this episode, Ayesha talks about Nestlé’s marketing of Seres Therapeutics’ oral microbiome drug for recurrent C. Difficile infection (CDI). CDIs typically develop after… Read More
GENEVA, Switzerland – World Health Organization (WHO) and Unitaid are concerned by Roche’s statement [yesterday], warning of a global shortage of tocilizumab (brand name Actemra… Read More
The severe inflammation in the blood vessels is referred to as Vasculitis. Inflammation is usually considered your immune system’s response to any infection or microorganism that has a… Read More
Steroidhormon
The effect of cbd bestellen legal deutschland. Kroppsbyggare kan lagligt äga anabola steroider för personligt bruk. Alle Inhalte sind nur zur Information gedacht. Ode… Read More
Para menteri kesehatan UE bertemu pada hari Selasa ketika pemerintah nasional meningkatkan langkah-langkah untuk mencoba mengekang varian Omicron Covid-19 yang menyebar di seluruh Eropa sa… Read More
Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are rec… Read More
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that Actemra®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification. Prequalificati… Read More
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and has… Read More
The conventional practices are being augmented through robotic, AI-driven systems, thereby taking the past as well as present to the future. This would, in true sense, let clinicians carve c… Read More
The conventional practices are being augmented through robotic, AI-driven systems, thereby taking the past as well as present to the future. This would, in true sense, let clinicians carve c… Read More
Rising occurrence of rheumatoid arthritis because of shift toward unhealthy lifestyle as well asincreasing research & development activities for better and permanent therapy alternatives… Read More
The conventional practices are being augmented through robotic, AI-driven systems, thereby taking the past as well as present to the future. This would, in true sense, let clinicians carve c… Read More
Rising occurrence of rheumatoid arthritis because of shift toward unhealthy lifestyle as well asincreasing research & development activities for better and permanent therapy alternatives… Read More
The most typical opposed reactions (incidence not less than 3%) reported had been constipation, urinary tract an infection, hypertension, anxiousness, diarrh… Read More
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Ac… Read More
These days, invasive fungal pathogens are making medical news — as well they should.
In Fall 2022, a World Health Organization (WHO) report named 19 key fungal threats, thus creati… Read More
Immunotherapy Drugs Market in terms of revenue was estimated to be worth $163.0 billion in 2020 and is poised to reach $274.6 billion by 2025, growing at a CAGR of 11.0% from 2020 to 20… Read More
The Janus kinase (JAK) inhibitor ruxolitinib (Jakafi) eased the severe inflammatory and dermatologic symptoms of disabling pansclerotic morphea (DPM), an initial clinical series showed.
Af… Read More
Immunotherapy Drugs Market in terms of revenue was estimated to be worth $163.0 billion in 2020 and is poised to reach $274.6 billion by 2025, growing at a CAGR of 11.0% from 2020 to 20… Read More
Actemra: Dosage, Uses and Side EffectsTocilizumab, the active ingredient in Actemra, is a brand-name prescription drug. It is an interleukin-6 (IL-6) antagonist, which works by inhibiting th… Read More
Treatment with at least some biologic drugs significantly reduced 1-year progression of early rheumatoid arthritis (RA) relative to classical small-molecule agents, researchers reported.
P… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
Rheumatoid arthritis (RA) is a chronic autoimmune condition that affects millions of people worldwide. It leads to painful joint inflammation, and stiffness, and can significantly reduce the… Read More
Note that some links may require registration or subscription.
The GOP’s physician lawmakers in Congress say the American Medical Association’s “wokeism” is straini… Read More
People who have severe, active rheumatoid arthritis (RA) and who are not sufficiently helped by nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed the drug methotrexat… Read More
The FDA has approved the first biosimilar version of the interleukin-6 (IL-6) blocker tocilizumab, to be marketed as Tofidence and with indications for rheumatoid arthritis (RA), systemic… Read More
Presented by 340B Health: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. Oct 03… Read More
MADRID — Patients with previously treated small-cell lung cancer (SCLC) obtained durable responses with either of two doses of the bispecific T cell-engaging (BiTE) antibody tarlata… Read More